Taylor Frigon Capital Management’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
PCM
LWM
PFSRSONJ
CA
VCM
CSB
FMP
CWP
GI
Taylor Frigon Capital Management's CLPT Position: Q2 2026 in Review
Taylor Frigon Capital Management increased its ClearPoint Neuro (CLPT) stake by 0.08% in Q2 2026, buying an estimated $1.35K and bringing the position to 132,009 shares worth $2.36M. The position accounts for 1.1% of the portfolio, ranked #35.
Taylor Frigon Capital Management first reported a position in CLPT in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.2M in Q3 2024. 21 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Taylor Frigon Capital Management held 132,009 shares of ClearPoint Neuro worth $2.36M as of Q2 2026.
- Taylor Frigon Capital Management bought 108 ClearPoint Neuro shares in Q2 2026, an estimated $1.35K.
- ClearPoint Neuro made up 1.1% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #35 holding.
- Taylor Frigon Capital Management first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 22 quarters since.
- Taylor Frigon Capital Management's ClearPoint Neuro position peaked at $4.2M in Q3 2024.
- 21 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.